IL1B and Obesity: Notably, IL-1β expression has been reported to be 1000-10,000-fold higher in subcutaneous and visceral adipose tissue compared to its expression in the liver of severely obese patients, pointing to the key contribution of adipose tissue to the chronic low-grade systemic inflammation observed in obesity [57].